NewAmsterdam Pharma Company N.V. Ordinary Shares
Symbol: NAMS (NASDAQ)
35.96
▼ (-0.91%) -0.330
Company Description:
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
Key Stats
- Today's Open: $36.6
- Today's High: $37.205
- Today's Low: $35.166
- Today's Volume: 746.40K
- Yesterday Close: $36.285
- Yesterday High: $36.74
- Yesterday Low: $34.66
- Yesterday Volume: 1.05M
- Last Min Volume: 3
- Last Min High: $35.955
- Last Min Low: $35.955
- Last Min VWAP: $35.955
Company Profile
- Name: NewAmsterdam Pharma Company N.V. Ordinary Shares
- Website: https://www.newamsterdampharma.com
- Listed Date: 2022-11-23
- Location: NARRDEN, P7
- Market Status: Active
- CIK Number: 0001936258
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $4.02B
- Round Lot: 100
- Outstanding Shares: 112.63M
- Asset Type: CS
RECENT FILINGS FOR NAMS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-30 | SCHEDULE 13D/A | View |
| 2025-09-17 | 4 | View |
| 2025-09-10 | 4 | View |
| 2025-09-10 | 4 | View |
| 2025-09-09 | 144 | View |
| 2025-09-05 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-03 | 144 | View |
| 2025-09-02 | 8-K | View |
| 2025-08-27 | 4 | View |
| 2025-08-27 | 144 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 144 | View |
| 2025-08-20 | SCHEDULE 13D/A | View |
| 2025-08-18 | 8-K | View |
| 2025-08-15 | 8-K | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13D/A | View |
| 2025-08-06 | 8-K | View |
Latest News on NAMS